• Home
  • The Company
    • Company Overview
    • Team
  • Technology
    • Technology Overview
    • Publications
  • Pipeline
  • Strategic Alliances
    • Science & Technical Collaborations
    • Investors & Financing
    • Partnerships
    • Patient Association
  • News & Media
    • In the News
  • Contact Us
Ahead Therapeutics – Fighting Autoimmune Diseases
Ahead Therapeutics - Fighting Autoimmune Diseases
 
  • Home
  • The Company
    • Company Overview
    • Team
  • Technology
    • Technology Overview
    • Publications
  • Pipeline
  • Strategic Alliances
    • Science & Technical Collaborations
    • Investors & Financing
    • Partnerships
    • Patient Association
  • News & Media
    • In the News
  • Contact Us
Ahead Therapeutics - Fighting Autoimmune Diseases
Home News & MediaPage 8

News & Media

Ahead Therapeutics – In the News


PRUAB NewsLetter. Ahead Therapeutics is granted 50.000 Euros from EU SME Instrument (Horizon 2020) for supporting a commercial treatment for Type 1 Diabetes
21st November 2018

PRUAB NewsLetter. Ahead Therapeutics is granted 50.000 Euros from EU SME Instrument (Horizon 2020) for supporting a commercial treatment for Type 1 Diabetes

Ahead Therapeutics has been one of the nine catalan companies chosen to be granted 50.000 Euros from European Union SME...
Read More
La Vanguardia. Drugs to repair the immunological system
12th September 2018

La Vanguardia. Drugs to repair the immunological system

The scientific community has so far identified almost a hundred autoimmune diseases, among which are type 1 diabetes, multiple sclerosis,...
Read More
La Vanguardia. A Catalan biotechnology company will develop therapies against autoimmune diseases
12th September 2018

La Vanguardia. A Catalan biotechnology company will develop therapies against autoimmune diseases

The biotechnology company Ahead Therapeutics will develop therapeutic products to fight against autoimmune diseases such as type 1 diabetes or...
Read More
« Previous 1 … 6 7 8 9 10 Next »

Our Company

Our Company
Privacy Policy
Terms and Conditions

Contents

Technology
Pipeline
Investors & Financing
Scientific & Technical Collaborations
Partnerships
Scientific Publications
News & Media

Latest News & Press Releases

  • Ahead Therapeutics will participate in the BIO International Convention – Digital – 2021 – 14-18 June
  • Ahead Therapeutics will attend to BIOEQUITY EUROPE 2021- 17-19 May
  • Ahead Therapeutics has been selected to participate in ANGLONORDIC LIFE SCIENCE CONFERENCE -2021- 25-26 May

Contact AHEAD THERAPEUTICS

AHEAD THERAPEUTICS S.L.
Parc de Recerca Edificio Eureka
(Universitat Autónoma de Barcelona)
08193 Cerdanyola del Vallès

Email
 
Back to Top

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 837515

This project has received funding from the CDTI (Centro para el desarrollo Tecnologico Industrial) under the NEOTEC project SNEO-20181206.
Este proyecto ha sido financiado por el CDTI mediante el instrumento NEOTEC SNEO-20181206.
 
Copyright AHEAD THERAPEUTICS S.L. 2018-2021 All rights reserved. Permissions must be obtained explicitly.
Design MOD by IDYMA Websolutions (Barcelona) .